Heart transplantation epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Ifrah Fatima (talk | contribs) |
||
| Line 6: | Line 6: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
Reporting of transplant statistics to the Registry of the International Society for Heart and Lung Transplantation (ISHLT) is required in the US, but not other countries. According to The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report — 2019: <ref name="pmid31548031">{{cite journal| author=Khush KK, Cherikh WS, Chambers DC, Harhay MO, Hayes D, Hsich E | display-authors=etal| title=The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report - 2019; focus theme: Donor and recipient size match. | journal=J Heart Lung Transplant | year= 2019 | volume= 38 | issue= 10 | pages= 1056-1066 | pmid=31548031 | doi=10.1016/j.healun.2019.08.004 | pmc=6816343 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31548031 }} </ref> | |||
===Incidence=== | ===Incidence=== | ||
*The | * The volume of heart transplants reported to the ISHLT Registry is significantly higher owing to increased donor availability. | ||
* | * Between 1980s-1990s there was a steady increase in the incidence of heart transplant but the numbers have since stabilized because of the limited number of donors. | ||
=== | ===Indications=== | ||
*The | * The leading indications for transplant in adult recipients are | ||
* | **non-ischemic [[dilated cardiomyopathy]]- 51% | ||
* | **[[ischemic cardiomyopathy]] 32% | ||
===Case-fatality rate/Mortality rate=== | ===Case-fatality rate/Mortality rate=== | ||
* | * Post-transplant survival has improved and the median survival after adult heart transplants performed between 2002 and 2009 is 12.5 years. | ||
* | * Causes of death in the long term have not changed in recent years. Death due to acute graft rejection is highest in the first 30 days and infectious complications are the leading cause in the first year. | ||
===Age=== | ===Age=== | ||
* | * Median recipient age is 55 years | ||
* | * Median donor age in Europe has increased to 45 years and remains relatively stable in North America at 28 years and other countries at 31 years. | ||
===Race=== | ===Race=== | ||
*There is no racial predilection to [disease name]. | *There is no racial predilection to [disease name]. | ||
*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name]. | *[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name]. | ||
===Gender=== | ===Gender=== | ||
*[Disease name] affects men and women equally. | *[Disease name] affects men and women equally. | ||
| Line 37: | Line 38: | ||
*[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2]. | *[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2]. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
Revision as of 18:34, 17 June 2020
|
Heart transplantation Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Heart transplantation epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Heart transplantation epidemiology and demographics |
|
Heart transplantation epidemiology and demographics in the news |
|
Blogs on Heart transplantation epidemiology and demographics |
|
Risk calculators and risk factors for Heart transplantation epidemiology and demographics |
Editor(s)-in-Chief: C. Michael Gibson, M.S., M.D.; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [1]
Overview
Epidemiology and Demographics
Reporting of transplant statistics to the Registry of the International Society for Heart and Lung Transplantation (ISHLT) is required in the US, but not other countries. According to The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report — 2019: [1]
Incidence
- The volume of heart transplants reported to the ISHLT Registry is significantly higher owing to increased donor availability.
- Between 1980s-1990s there was a steady increase in the incidence of heart transplant but the numbers have since stabilized because of the limited number of donors.
Indications
- The leading indications for transplant in adult recipients are
- non-ischemic dilated cardiomyopathy- 51%
- ischemic cardiomyopathy 32%
Case-fatality rate/Mortality rate
- Post-transplant survival has improved and the median survival after adult heart transplants performed between 2002 and 2009 is 12.5 years.
- Causes of death in the long term have not changed in recent years. Death due to acute graft rejection is highest in the first 30 days and infectious complications are the leading cause in the first year.
Age
- Median recipient age is 55 years
- Median donor age in Europe has increased to 45 years and remains relatively stable in North America at 28 years and other countries at 31 years.
Race
- There is no racial predilection to [disease name].
- [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
Gender
- [Disease name] affects men and women equally.
- [Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
Region
- The majority of [disease name] cases are reported in [geographical region].
- [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
Epidemiology and Demographics
Reporting of transplant statistics to the Registry of the International Society for Heart and Lung Transplantation (ISHLT) is required in the US, but not other countries. According to The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report — 2019: [1]
- The volume of heart transplants reported to the ISHLT Registry is significantly higher owing to increased donor availability.
- Median recipient age is 55 years
- Median donor age in Europe has increased to 45 years and remains relatively stable in North America at 28 years and other countries at 31 years.
- The leading indications for transplant in adult recipients are
- non-ischemic dilated cardiomyopathy- 51%
- ischemic cardiomyopathy 32%
- Post transplant survival has improved and the median survival after adult heart transplants performed between 2002 and 2009 is 12.5 years.
- Causes of death in the long term have not changed in recent years. Death due to acute graft rejection is highest in the first 30 days and infectious complications is leading cause in the first year.
References
- ↑ 1.0 1.1 Khush KK, Cherikh WS, Chambers DC, Harhay MO, Hayes D, Hsich E; et al. (2019). "The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report - 2019; focus theme: Donor and recipient size match". J Heart Lung Transplant. 38 (10): 1056–1066. doi:10.1016/j.healun.2019.08.004. PMC 6816343 Check
|pmc=value (help). PMID 31548031.